Further studies that examine the co-immunostaining of a-synuclein and LRRK2 in those with preceding gastrointestinal symptoms, brainstem dysfunctional symptoms of rapid eye movement sleep behavior disorder or having LRRK2 risk variants are needed to confirm our hypothesis. The gene discussed is LRRK2; the disease is REM sleep behavior disorder.